주요서비스 바로가기
본문 바로가기
매체정보 바로가기
로그인 바로가기
기사검색 바로가기
전체서비스 바로가기
상단영역
UPDATE : 2024-04-26 16:52 (Fri)
Home
Log in
Join
전체메뉴
기사검색
검색
본문영역
Policy
목록
(
총 :
918 )
기사목록 보기 형태
제목형
요약형
포토형
AstraZeneca’s neurofibromatosis drug Koselugo gets insurance coverage
Kim Jung-chul
2024.01.02 15:46
KDCA shifts to full monitoring of syphilis to prevent the spread
Kwak Sung-sun
2024.01.02 15:34
Korea’s healthcare workers increase 3.7% to 1.04 million
Yang Hyeon-su
2023.12.29 16:51
‘Industry welcomes telemedicine pilot project but faces lots of homework’
Kim Chan-hyuk
2023.12.29 15:54
Government seeks innovative mental health policy, but parliament stresses sustainability
Kwak Sung-sun
2023.12.29 12:24
[Top 10 Healthcare News in 2023 ⑩] Controversy continues over drug quality amid frequent mislabeling
Korea Biomedical Review
2023.12.29 12:24
[Top 10 Healthcare News in 2023 ⑧] Alarm bells of collapsing essential care were heard everywhere
Korea Biomedical Review
2023.12.28 16:50
Recipients of support for rare disease diagnosis ‘tripled’ this year
Kwak Sung-sun
2023.12.28 15:10
As cancer screenings increase after Covid-19 declines, cases rebound
Kim Ju-yeon
2023.12.28 15:06
Korean medicine practitioners demand the correct use of their title
Koh Jung Min
2023.12.28 12:46
[Top 10 Healthcare News in 2023 ⑤] Telemedicine pilot project starts without law amendment
Korea Biomedical Review
2023.12.27 16:23
Korea to cut insurance for lower abdominal/urinary ultrasounds starting 2024
Kim Eun-young
2023.12.27 10:28
처음
이전
이전
1
2
3
4
5
6
7
8
9
10
다음
다음
다음
끝
위로
전체메뉴
All
Hospital
Pharma
Bio
All
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
All
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
ASCO 2020 Highlights
Special Series in Celebration of KBR’s 4th Anniversary
KBR Covering RSNA 2021
Special Series in Celebration of KBR’s 5th Anniversary
Special Report on EULAR 2022
[Top K-Pharma Analysis]
BIO 2023
Opinion
All
Reporter’s Notebook
Journalist’s Column
Congratulatory Remarks
Sponsored
전체메뉴닫기